GB0117618D0 - Pharmaceutical dosage form - Google Patents

Pharmaceutical dosage form

Info

Publication number
GB0117618D0
GB0117618D0 GBGB0117618.9A GB0117618A GB0117618D0 GB 0117618 D0 GB0117618 D0 GB 0117618D0 GB 0117618 A GB0117618 A GB 0117618A GB 0117618 D0 GB0117618 D0 GB 0117618D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
pharmaceutical dosage
pharmaceutical
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0117618.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoqus Ltd
Original Assignee
Phoqus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoqus Ltd filed Critical Phoqus Ltd
Priority to GBGB0117618.9A priority Critical patent/GB0117618D0/en
Publication of GB0117618D0 publication Critical patent/GB0117618D0/en
Priority to KR10-2004-7000801A priority patent/KR20040032857A/ko
Priority to EP02745646A priority patent/EP1406597A1/fr
Priority to CNA028184734A priority patent/CN1556697A/zh
Priority to PCT/GB2002/003286 priority patent/WO2003007919A1/fr
Priority to US10/484,734 priority patent/US20060099257A1/en
Priority to RU2004104950/15A priority patent/RU2004104950A/ru
Priority to JP2003513528A priority patent/JP2005501039A/ja
Priority to CA002457308A priority patent/CA2457308A1/fr
Priority to IL15987602A priority patent/IL159876A0/xx
Priority to JP2003513528D priority patent/JP2005519858A/ja
Priority to BR0211156-0A priority patent/BR0211156A/pt
Priority to MXPA04000544A priority patent/MXPA04000544A/es
Priority to AU2002317360A priority patent/AU2002317360B2/en
Priority to ZA200401216A priority patent/ZA200401216B/xx
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0117618.9A 2001-07-19 2001-07-19 Pharmaceutical dosage form Ceased GB0117618D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB0117618.9A GB0117618D0 (en) 2001-07-19 2001-07-19 Pharmaceutical dosage form
AU2002317360A AU2002317360B2 (en) 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates
RU2004104950/15A RU2004104950A (ru) 2001-07-19 2002-07-18 Системы с регулируемой доставкой лекарственных средств, обеспечивающие переменные скорости высвобождения
CA002457308A CA2457308A1 (fr) 2001-07-19 2002-07-18 Systemes d'administration controlee de medicaments offrant des taux de liberation variables
CNA028184734A CN1556697A (zh) 2001-07-19 2002-07-18 提供可变释放速率的受控药物递送系统
PCT/GB2002/003286 WO2003007919A1 (fr) 2001-07-19 2002-07-18 Systemes d'administration controlee de medicaments offrant des taux de liberation variables
US10/484,734 US20060099257A1 (en) 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates
KR10-2004-7000801A KR20040032857A (ko) 2001-07-19 2002-07-18 가변 방출 속도를 제공하는 조절 약물 전달 시스템
JP2003513528A JP2005501039A (ja) 2001-07-19 2002-07-18 可変放出割合を持つ薬剤制御放出システム
EP02745646A EP1406597A1 (fr) 2001-07-19 2002-07-18 Systemes d'administration controlee de medicaments offrant des taux de liberation variables
IL15987602A IL159876A0 (en) 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates
JP2003513528D JP2005519858A (ja) 2001-07-19 2002-07-18 可変放出割合を持つ薬剤制御放出システム
BR0211156-0A BR0211156A (pt) 2001-07-19 2002-07-18 Forma de dosagem de liberação controlada com taxas de liberação variáveis
MXPA04000544A MXPA04000544A (es) 2001-07-19 2002-07-18 Sistemas controlados de administracion de medicamentos que proporcionan velocidades de liberacion variables.
ZA200401216A ZA200401216B (en) 2001-07-19 2004-02-16 Controlled drug delivery systems providing variable release rates.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0117618.9A GB0117618D0 (en) 2001-07-19 2001-07-19 Pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
GB0117618D0 true GB0117618D0 (en) 2001-09-12

Family

ID=9918808

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0117618.9A Ceased GB0117618D0 (en) 2001-07-19 2001-07-19 Pharmaceutical dosage form

Country Status (14)

Country Link
US (1) US20060099257A1 (fr)
EP (1) EP1406597A1 (fr)
JP (2) JP2005501039A (fr)
KR (1) KR20040032857A (fr)
CN (1) CN1556697A (fr)
AU (1) AU2002317360B2 (fr)
BR (1) BR0211156A (fr)
CA (1) CA2457308A1 (fr)
GB (1) GB0117618D0 (fr)
IL (1) IL159876A0 (fr)
MX (1) MXPA04000544A (fr)
RU (1) RU2004104950A (fr)
WO (1) WO2003007919A1 (fr)
ZA (1) ZA200401216B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002333644A1 (en) 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
TW200517127A (en) * 2003-08-07 2005-06-01 Sb Pharmco Inc Novel composition
AR046410A1 (es) 2003-09-18 2005-12-07 Cephalon Inc Composiciones farmaceuticas para la liberacion modificada de modafinilo
CA2540059C (fr) * 2003-09-26 2013-08-06 Alza Corporation Formulations a liberation commandee presentant un taux croisssant de liberation
AU2004275816A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
ATE504288T1 (de) * 2003-09-26 2011-04-15 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
ATE544447T1 (de) * 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7390524B1 (en) 2004-05-20 2008-06-24 Advanced Cardiovascular Systems, Inc. Method for electrostatic spraying of an abluminal stent surface
NZ552841A (en) * 2004-08-04 2009-07-31 Alza Corp Controlled release dosage form comprising two layers, wherein the delay layer is substanially free of non-microencapsulated drug
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
ES2379117T3 (es) 2006-05-16 2012-04-20 Knopp Neurosciences, Inc. Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
EP2465500A1 (fr) 2006-05-16 2012-06-20 Knopp Neurosciences, Inc. Quantités thérapeutiquement efficaces de R(+) et S(-) pramipexole pour une utilisation dans le traitement de la maladie de Parkinson
JP5410964B2 (ja) * 2006-05-23 2014-02-05 オラヘルス コーポレーション 付着性アカシアゴムを含む二層構造の口腔内付着錠
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) * 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
WO2009122431A2 (fr) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd., Comprimé oral à libération contrôlée
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
US8343524B2 (en) 2008-07-31 2013-01-01 Clarke Mosquito Control Products, Inc. Extended release tablet and method for making and using same
WO2010017821A1 (fr) * 2008-08-14 2010-02-18 Daniel Bar-Shalom Comprimés enrobés avec une surface de dégradation résiduelle dans le temps
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2010148409A1 (fr) * 2009-06-19 2010-12-23 Knopp Neurosciences, Inc. Compositions et méthodes pour traiter la sclérose latérale amyotrophique (als)
US20120070465A1 (en) 2010-03-29 2012-03-22 Astellas Pharma Inc. Pharmaceutical composition for modified release
EP2481411A1 (fr) * 2011-01-27 2012-08-01 Ratiopharm GmbH Formes galéniques orales pour libération modifiée comportant l'inhibiteur de JAK3 tasocitinib
LT5850B (lt) 2011-08-31 2012-07-25 Česlovas Paplauskas Vertikalaus srauto išorinis fazės apgręžiklis garso monitoriams
US8697118B2 (en) * 2011-10-18 2014-04-15 St. Teresa Medical, Inc. Stabilizers for hemostatic products
EP4035683A1 (fr) 2011-12-12 2022-08-03 Adare Pharmaceuticals USA, Inc. Formulations de particules à libération prolongée
WO2013096816A1 (fr) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Synthèse améliorée de composés substitués par amine de 4,5,6,7-tétrahydrobenzothiazole
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
LT3019167T (lt) 2013-07-12 2021-03-25 Knopp Biosciences Llc Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
AU2014306597B2 (en) 2013-08-13 2018-05-17 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
EP3038467B1 (fr) 2013-08-13 2020-07-29 Knopp Biosciences LLC Compositions et méthodes de traitement de troubles des cellules plasmatiques et de troubles prolymphocytaires à cellules b
WO2015117004A1 (fr) * 2014-01-31 2015-08-06 Board Of Regents, The University Of Texas System Procédé de préparation de films
KR20180014778A (ko) 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
KR20230157528A (ko) 2017-01-26 2023-11-16 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
CN115645374B (zh) * 2022-12-25 2024-04-26 山东理工职业学院 一种硫酸沙丁胺醇片的制备方法
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
ATE293440T1 (de) * 1995-05-09 2005-05-15 Phoqus Pharmaceuticals Ltd Pulverbeschichtungszusammensetzung für elektrostatische beschichtung von pharmazeutischen substraten
MXPA01010377A (es) * 1999-04-13 2002-10-23 Beecham Pharm Pte Ltd Metodo novedoso de tratamiento.

Also Published As

Publication number Publication date
EP1406597A1 (fr) 2004-04-14
IL159876A0 (en) 2004-06-20
CN1556697A (zh) 2004-12-22
MXPA04000544A (es) 2005-06-06
JP2005501039A (ja) 2005-01-13
RU2004104950A (ru) 2005-03-10
WO2003007919A1 (fr) 2003-01-30
BR0211156A (pt) 2004-08-10
CA2457308A1 (fr) 2003-01-30
US20060099257A1 (en) 2006-05-11
KR20040032857A (ko) 2004-04-17
AU2002317360B2 (en) 2006-08-17
ZA200401216B (en) 2005-03-17
JP2005519858A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
GB0117618D0 (en) Pharmaceutical dosage form
IL154012A0 (en) Hydrogel-driven drug dosage form
IL156716A0 (en) Pharmaceutical formulation
EP1450824A4 (fr) Composition pharmaceutique
GB0117619D0 (en) Pharmaceutical dosage form
GB0118689D0 (en) Pharmaceutical formulation
GB0104534D0 (en) Pharmaceutical combination
PL366432A1 (en) Pharmaceutical formulation
PL366510A1 (en) Pharmaceutical combinations
GB0117057D0 (en) Pharmaceutical composition
EP1408896A4 (fr) Composition pharmaceutique
GB0101227D0 (en) Pharmaceutical compounds
GB0101225D0 (en) Pharmaceutical compounds
GB0129117D0 (en) Pharmaceutical composition
GB0124523D0 (en) Pharmaceutical combination
GB0116107D0 (en) Pharmaceutical composition
GB0129270D0 (en) Pharmaceutical combination
GB0129397D0 (en) Pharmaceutical combination
GB0129395D0 (en) Pharmaceutical combination
AU2002342940A8 (en) New pharmaceutical compounds
GB0128138D0 (en) Pharmaceutical use
GB0104749D0 (en) Pharmaceutical formulation
IL134581A0 (en) Pharmaceutical dosage form
GB0121677D0 (en) Dosage
GB0113345D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)